Novartis’ drug Afinitor has been approved by US authorities as a first line treatment for patients with benign brain tumours …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

